Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Sharon

Showing results (261-270 of 292) with videos related to

Pageof 30
Sort By:
Allergy|December 14, 2024
Efficacy and Safety of Dupilumab in Children With Peanut Allergy: A Multicenter, Open-Label, Phase II StudySayantani B Sindher, Kari C Nadeau, R Sharon Chinthrajah, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 9, 2026
Biologics and Novel Therapeutics in Food AllergyBrent Anderson, Claire Pascal, M Gohazrua K Butler, et al.
JAMA Dermatology|March 16, 2017
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Standard Reporting and Evaluation Guidelines: Results of a National Institutes of Health Working GroupEmanual Maverakis, Elizabeth A Wang, Kanade Shinkai, et al.
The Journal of Allergy and Clinical Immunology|September 10, 2016
Omalizumab facilitates rapid oral desensitization for peanut allergyAndrew J MacGinnitie, Rima Rachid, Hana Gragg, et al.
JAMA Network Open|September 17, 2021
Assessment of Allergic and Anaphylactic Reactions to mRNA COVID-19 Vaccines With Confirmatory Testing in a US Regional Health SystemChristopher Michael Warren, Theo Thomas Snow, Alexandra S Lee, et al.
The Journal of Allergy and Clinical Immunology|March 5, 2023
The role of biologics in pediatric food allergy and eosinophilic gastrointestinal disordersSayantani B Sindher, Suzanne Barshow, Jyothi Tirumalasetty, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 6, 2026
Management of gastrointestinal symptoms during oral immunotherapy: Guidance from OUtMATCH InvestigatorsSayantani B Sindher, Mirna Chehade, Evan S Dellon, et al.
Allergy|December 14, 2024
Dupilumab as an Adjunct to Oral Immunotherapy in Pediatric Patients With Peanut AllergyR Sharon Chinthrajah, Sayantani B Sindher, Kari C Nadeau, et al.
The Journal of Allergy and Clinical Immunology. Global|October 2, 2023
Protocol design and synopsis: Omalizumab as Monotherapy and as Adjunct Therapy to Multiallergen OIT in Children and Adults with Food Allergy (OUtMATCH)Robert A Wood, R Sharon Chinthrajah, Amanda K Rudman Spergel, et al.
JAMA Dermatology|March 7, 2019
Development and Validation of a Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis-ABCD-10Megan H Noe, Misha Rosenbach, Rebecca A Hubbard, et al.
Pageof 30

Showing results (261-270 of 292) with videos related to

Sort By:
Pageof 30
Allergy|December 14, 2024
Efficacy and Safety of Dupilumab in Children With Peanut Allergy: A Multicenter, Open-Label, Phase II StudySayantani B Sindher, Kari C Nadeau, R Sharon Chinthrajah, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 9, 2026
Biologics and Novel Therapeutics in Food AllergyBrent Anderson, Claire Pascal, M Gohazrua K Butler, et al.
JAMA Dermatology|March 16, 2017
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Standard Reporting and Evaluation Guidelines: Results of a National Institutes of Health Working GroupEmanual Maverakis, Elizabeth A Wang, Kanade Shinkai, et al.
The Journal of Allergy and Clinical Immunology|September 10, 2016
Omalizumab facilitates rapid oral desensitization for peanut allergyAndrew J MacGinnitie, Rima Rachid, Hana Gragg, et al.
JAMA Network Open|September 17, 2021
Assessment of Allergic and Anaphylactic Reactions to mRNA COVID-19 Vaccines With Confirmatory Testing in a US Regional Health SystemChristopher Michael Warren, Theo Thomas Snow, Alexandra S Lee, et al.
The Journal of Allergy and Clinical Immunology|March 5, 2023
The role of biologics in pediatric food allergy and eosinophilic gastrointestinal disordersSayantani B Sindher, Suzanne Barshow, Jyothi Tirumalasetty, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 6, 2026
Management of gastrointestinal symptoms during oral immunotherapy: Guidance from OUtMATCH InvestigatorsSayantani B Sindher, Mirna Chehade, Evan S Dellon, et al.
Allergy|December 14, 2024
Dupilumab as an Adjunct to Oral Immunotherapy in Pediatric Patients With Peanut AllergyR Sharon Chinthrajah, Sayantani B Sindher, Kari C Nadeau, et al.
The Journal of Allergy and Clinical Immunology. Global|October 2, 2023
Protocol design and synopsis: Omalizumab as Monotherapy and as Adjunct Therapy to Multiallergen OIT in Children and Adults with Food Allergy (OUtMATCH)Robert A Wood, R Sharon Chinthrajah, Amanda K Rudman Spergel, et al.
JAMA Dermatology|March 7, 2019
Development and Validation of a Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis-ABCD-10Megan H Noe, Misha Rosenbach, Rebecca A Hubbard, et al.
Pageof 30